Clinical Trials for Sonnet BioTherapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Sonnet BioTherapeutics

Clinical Trials (1)

NCT05756907
Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer
PHASE1/PHASE2Recruiting
165 participants
Started: Sep 15, 2023 · Completed: May 30, 2025
2 conditions2 sponsors4 locations